- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 317/66 - Atomes d'azote ne faisant pas partie d'un radical nitro
Détention brevets de la classe C07D 317/66
Brevets de cette classe: 87
Historique des publications depuis 10 ans
|
5
|
18
|
11
|
9
|
8
|
2
|
5
|
3
|
10
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
4 |
| The University of Sydney | 562 |
4 |
| The Regents of the University of California | 18943 |
3 |
| The Scripps Research Institute | 1364 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 248 |
3 |
| Elanco Tiergesundheit AG | 452 |
3 |
| BASF SE | 19740 |
2 |
| Abbvie Inc. | 1808 |
2 |
| AbbVie Deutschland GmbH & Co. KG | 268 |
2 |
| Adeka Corporation | 1333 |
2 |
| Council of Scientific & Industrial Research | 1397 |
2 |
| Flexus Biosciences, Inc. | 13 |
2 |
| The Florida International University Board of Trustees | 548 |
2 |
| Metabasis Therapeutics, Inc. | 48 |
2 |
| Nihon Nohyaku Co., Ltd. | 313 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
2 |
| The University of British Columbia | 1432 |
2 |
| Firmenich Incorporated | 124 |
2 |
| F. Hoffmann-La Roche AG | 7958 |
1 |
| Abbott Laboratories | 2542 |
1 |
| Autres propriétaires | 41 |